Komori
Alfresa Holdings (2784) · FactFirst stated

Revenue and profit growth in the self-medication wholesale business in FY2024 Q3

First written in FY2024-Q3. . Latest entry: FY2024-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Recovery in the Self-Medication Wholesale Market Driven by the Recovery in Foot Traffic and Inbound DemandA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3First statedAnnual report

    「当セグメントの当第３四半期連結累計期間の業績は、新型コロナウイルス感染症の「５類」移行後の人流回復に加えて、訪日外国人増加によるインバウンド需要増に伴う市場回復の影響から増収となったこと等により、売上高2,003億61百万円(前年同期比7.3％増)、営業利益21億80百万円(同31.1％増)となりました。」

    人流回復と訪日外国人増加によるインバウンド需要増に伴う市場回復等により増収増益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.